Evidence map›Paper›PMID 41028169›Full record

ArticleCommunications biology2025

Pancreatic β-cell FFA2 deficiency suppresses multiple low dose streptozotocin induced diabetes in male mice.

Kai Xu, Prabhakaran Kumar, Sophia R Chang Stauffer, Husena M Electricwala, Bellur S Prabhakar, Irene Corona-Avila, Nupur Pandya, Brian T Layden, Medha Priyadarshini

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kai XuDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA.
Prabhakaran KumarDepartment of Microbiology and Immunology, University of Illinois Chicago, Chicago, IL, USA.
Sophia R Chang StaufferDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-1072-737X
Husena M ElectricwalaDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA.
Bellur S PrabhakarDepartment of Microbiology and Immunology, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-9815-9850
Irene Corona-AvilaDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA.
Nupur PandyaDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA.
Brian T LaydenDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA.
Medha PriyadarshiniDepartment of Medicine; Division of Endocrinology, Diabetes and Metabolism, University of Illinois Chicago, Chicago, IL, USA. mpriya2@uic.edu.ORCID http://orcid.org/0000-0003-2972-2528

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI GRAEME I BELL, Raghavendra G Mirmira · 2013 to 2026
$20.9M
The function and regulation of the novel pregnancy-specific hexokinase HKDC1R01DK104927 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAYDEN, BRIAN THOMAS, REDDY, TIMOTHY E · 2015 to 2024
$7.2M
BLRD VA I01 BX003382NIDDK NIH HHS P30 DK020595NIDDK NIH HHS R01 DK104927U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30DK020595 DRTC P&F grant (B.T.L; M.P)U.S. Department of Veterans Affairs (Department of Veterans Affairs) 1I01BX003382(B.T.L)
6 · The paper itself

Abstract

Reduced enrichment of short-chain fatty acid (SCFA)-producing pathways in the gut microbiome (GM) and SCFA levels are associated with increased risk of type 1 diabetes (T1D). Free fatty acid receptor 2 (FFA2), an SCFA receptor on pancreatic β-cells, mediates GM and β-cell crosstalk. Here, we examine its T1D-specific role in male mice, using a novel tamoxifen-inducible adult-onset β-cell FFA2 knockout (FFA2 βKO) mouse model and its controls (cre and flox), treated with multiple low-dose streptozotocin (MLDS). FFA2 βKO mice show significantly lower diabetes incidence compared to control mice (57% vs 100%). Early in the MLDS insult (7

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Insulin-Secreting CellsReceptors, G-Protein-CoupledAnimalsApoptosisMaleMiceMice, Inbred C57BLMice, KnockoutSignal TransductionStreptozocinFfar2 protein, mouseReceptors, G-Protein-CoupledStreptozocin

Identifiers

PMID41028169
PMCPMC12484839

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.